Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04713943Not ApplicableCompleted

Efficacy of >Your< Iron Syrup Supplementation in Children With Dietary Iron Deficiency

Role: collaborator

NCT03738761Phase 4Completed

Management of Newly Diagnosed and Uncontrolled Hypertension With Fixed-Dose Combination of Perindopril/Amlodipine and Perindopril/Indapamide/Amlodipine

Role: collaborator

NCT04093206Not ApplicableCompleted

Compare Effects of EpiCor and Vitamin C to Vitamin C Alone on the Common Cold or Influenza in Healthy Children

Role: collaborator

NCT02391220Not ApplicableCompleted

Assessment of the Symbiotic Fermented Milk in Patients With Irritable Bowel Syndrome

Role: lead

All 4 trials loaded